Bio-Rad Laboratories Inc (BIO) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics.

Total Assets Chart for Bio-Rad Laboratories Inc

Bio-Rad Laboratories Inc (BIO) total assets for FY2025 were USD 10.6B, a 12.9% change from FY2024. Bio-Rad Laboratories Inc's total assets grew from USD 71.5M in 1985 to USD 10.6B in 2025 (14692.3% over 40 years). Total assets compound annual growth rate: 5-year CAGR of -4.0%, 10-year CAGR of 11.0%, 20-year CAGR of 10.5%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$9.87B
Implied Share Price
$454.85
Enterprise Value
$9.81B
Revenue (TTM)
$2.59B
EBITDA
$441.00M
Profit Margin
8.59%
Trailing P/E
48.15
Forward P/E
41.32
Price/Book (MRQ)
1.41
Price/Sales (TTM)
3.81
EV/EBITDA
17.28
EV/Revenue
3.79
Dividend Yield
—
Book Value
$268.30
Free Cash Flow (FY2025)
$374.60M
Free Cash Flow Yield
3.80%

Snapshot as of 6th October 2026 — not point-in-time controlled, may lag the live market by a few days.